Items tagged with Guidelines
WHO announces landmark changes in MDR-TB treatment regimens (post with simple image)
Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.
The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB (post with simple image)
The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.
WHO updates its treatment guidelines for MDR/RR-TB (post with simple image)
The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.
New WHO recommendations to accelerate progress on TB (post with simple image)
WHO issues new guidance to improve treatment of multidrug-resistant TB.
Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB (post with simple image)
Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.
Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB (post with simple image)
Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.
Public call for individual patient data on treatment of drug-resistant TB (post with simple image)
The World Health Organization issues a public call for individual patients data on rifampicin-resistant and multidrug-resistant TB treatment outcomes.
Update of WHO guidelines on the programmatic management of drug-resistant TB (post with simple image)
End-users (i.e. policy makers; health professionals, including doctors, nurses and educators working in governmental and non-governmental organizations; TB patients) interested in providing comments on the scope of this guideline update are invited to submit their feedback.
WHO updates policy for the use of TB LAM test (post with simple image)
The World Health Organization now recommends more broader use of urinary LAM assays for diagnosis of TB in people living with HIV.
ATS, CDC, ERS and IDSA publish new clinical guideline for the treatment and prevention of drug-resistant TB (post with simple image)
New guideline emphasizes treatment of drug-resistant TB with all-oral regimens and provides recommendations for treatment of all contacts to multidrug-resistant TB patients.
Page 10 of 11 · Total posts: 0←First 9 10 11 Last→